Pentwater Capital Management LP Tela Bio, Inc. Transaction History

Pentwater Capital Management LP

$15 Billion
Q2 2025

A detailed history of Pentwater Capital Management LP transactions in Tela Bio, Inc. stock. As of the latest transaction made, Pentwater Capital Management LP holds 815,000 shares of TELA stock, worth $986,150. This represents 0.01% of its overall portfolio holdings.

Number of Shares

815,000

Previous 998,755 18.4%

Holding current value

$986,150

Previous $1.22 Million 29.8%

% of portfolio

0.01%

Previous 0.01%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 14, 2025	SELL	$0.89 - $1.95 $163,541 - $358,322	-183,755 Reduced 18.4%	815,000 $1.58 Million
Q1 2025 May 15, 2025	SELL	$1.22 - $2.91 $1,518 - $3,622	-1,245 Reduced 0.12%	998,755 $1.22 Million
Q4 2024 Feb 14, 2025	BUY	$2.38 - $3.14 $1.19 Million - $1.57 Million	500,000 Added 100.0%	1,000,000 $3.02 Million
Q3 2024 Nov 14, 2024	BUY	$2.32 - $5.04 $231,999 - $504,000	100,000 Added 25.0%	500,000 $1.27 Million
Q2 2024 Jul 31, 2024	BUY	$4.39 - $6.36 $401,061 - $581,036	91,358 Added 29.6%	400,000 $1.88 Million
Q1 2024 May 15, 2024	SELL	$5.3 - $7.61 $3.61 Million - $5.19 Million	-681,358 Reduced 68.82%	308,642 $1.75 Million
Q4 2023 Feb 14, 2024	BUY	$4.5 - $7.51 $292,500 - $488,150	65,000 Added 7.03%	990,000 $6.55 Million
Q3 2023 Nov 14, 2023	BUY	$7.85 - $10.68 $362,677 - $493,426	46,201 Added 5.26%	925,000 $7.4 Million
Q2 2023 Aug 14, 2023	BUY	$9.23 - $11.23 $3.58 Million - $4.36 Million	388,397 Added 79.2%	878,799 $8.9 Million
Q1 2023 May 15, 2023	SELL	$9.41 - $12.03 $721,154 - $921,943	-76,637 Reduced 13.52%	490,402 $5.22 Million
Q4 2022 Feb 14, 2023	SELL	$6.5 - $11.5 $56,296 - $99,601	-8,661 Reduced 1.5%	567,039 $6.52 Million
Q3 2022 Nov 14, 2022	BUY	$7.36 - $9.15 $1.37 Million - $1.7 Million	185,700 Added 47.62%	575,700 $4.91 Million
Q2 2022 Aug 15, 2022	BUY	$5.54 - $11.49 $430,801 - $893,485	77,762 Added 24.9%	390,000 $2.73 Million
Q4 2021 Feb 11, 2022	BUY	$11.95 - $13.34 $12,212 - $13,633	1,022 Added 0.33%	312,238 $4 Million
Q3 2021 Nov 15, 2021	BUY	$12.2 - $15.93 $114,460 - $149,455	9,382 Added 3.11%	311,216 $4.25 Million
Q2 2021 Aug 16, 2021	BUY	$11.7 - $16.11 $313,957 - $432,295	26,834 Added 9.76%	301,834 $4.86 Million
Q1 2021 May 17, 2021	SELL	$12.84 - $17.26 $88,133 - $118,472	-6,864 Reduced 2.44%	275,000 $4.1 Million
Q3 2020 Nov 16, 2020	BUY	$11.64 - $16.86 $50,843 - $73,644	4,368 Added 1.57%	281,864 $4.66 Million
Q2 2020 Aug 14, 2020	BUY	$7.75 - $22.61 $1.66 Million - $4.84 Million	214,208 Added 338.47%	277,496 $3.6 Million
Q1 2020 May 15, 2020	BUY	$5.39 - $18.33 $54,164 - $184,198	10,049 Added 18.88%	63,288 $495,000
Q4 2019 Feb 14, 2020	BUY	$11.26 - $13.8 $599,471 - $734,698	53,239 New	53,239 $689,000

Others Institutions Holding TELA

# of Institutions

Shares Held

23.7M

Call Options Held

764K

Put Options Held

View Full List

About TELA Bio, Inc.

Ticker TELA
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 19,157,600
Market Cap $23.2M
Description
TELA Bio, Inc., a commercial-stage medical technology company, focuses on providing soft-tissue reconstruction solutions that optimize clinical outcomes by prioritizing the preservation and restoration of the patient's anatomy. It provides a portfolio of OviTex Reinforced Tissue Matrix (OviTex) products for hernia repair and abdominal wall recon...

More about TELA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Pentwater Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Pentwater Capital Management LP with notifications on news.

Account

Pentwater Capital Management LP Tela Bio, Inc. Transaction History